PM
EDVA

Phraction Management’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Phraction Management’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2K Buy
30,912
+13,412
+77% +$13.9K ﹤0.01% 66
2026
Q1 		$25.1K Buy
+17,500
New +$40.5K 0.01% 64

Other funds holding EDVA

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Phraction Management's EDVA Position: Q2 2026 in Review

Phraction Management increased its Endovia Health Sciences, Inc. (EDVA) stake by 77% in Q2 2026, buying an estimated $13.9K and bringing the position to 30,912 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #66.

Phraction Management first reported a position in EDVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $25.1K in Q1 2026. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • Phraction Management held 30,912 shares of Endovia Health Sciences, Inc. worth $19.2K as of Q2 2026.
  • Phraction Management bought 13,412 Endovia Health Sciences, Inc. shares in Q2 2026, an estimated $13.9K.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Phraction Management's portfolio in Q2 2026, its #66 holding.
  • Phraction Management first reported a position in Endovia Health Sciences, Inc. in Q1 2026 and has held it in 2 quarters since.
  • Phraction Management's Endovia Health Sciences, Inc. position peaked at $25.1K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on Phraction Management's 13F filing for Q2 2026, filed 20 Jul 2026.